Patents by Inventor Gerard McLachlan

Gerard McLachlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lentiviral vectors
    Patent number: 10704061
    Abstract: This invention relates to lentiviral gene transfer vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a promoter and a transgene; and methods of making the same. The present invention also relates to the use of said vectors in gene therapy, particularly for the treatment of respiratory tract diseases such as Cystic Fibrosis (CF).
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: July 7, 2020
    Assignees: IP2IPO INNOVATIONS LIMITED, ID PHARMA CO., LTD.
    Inventors: Eric Walter Frederick Wolfgang Alton, Uta Griesenbach, Kamila Malgorzata Pytel, Michael Christian Paul-Smith, Ian Andrew Pringle, Stephen Charles Hyde, Deborah Rebecca Gill, Lee Adrian Davies, Alan Christopher Boyd, Gerard McLachlan, Makoto Inoue
  • LENTIVIRAL VECTORS
    Publication number: 20170096684
    Abstract: This invention relates to lentiviral gene transfer vectors pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a promoter and a transgene; and methods of making the same. The present invention also relates to the use of said vectors in gene therapy, particularly for the treatment of respiratory tract diseases such as Cystic Fibrosis (CF).
    Type: Application
    Filed: April 23, 2015
    Publication date: April 6, 2017
    Inventors: Eric Walter Frederick Wolfgang Alton, Uta Griesenbach, Kamila Malgorzata Pytel, Michael Christian Paul-Smith, Ian Andrew Pringle, Stephen Charles Hyde, Deborah Rebecca Gill, Lee Adrian Davies, Alan Christopher Boyd, Gerard McLachlan, Makoto Inoue